Lawrence Steinman Pasithea Therapeutics Corp. (KTTA) insider trading activity
Lawrence Steinman is Director of Pasithea Therapeutics Corp.. Currently has a direct ownership of 1.33 Million shares of KTTA, which is worth approximately $3.42 Million. The most recent transaction as insider was on Jun 02, 2023, when has been sold 30,000 shares (Common Stock) at a price of $0.43 per share, resulting in proceeds of $12,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.33M
0%
3M change
0%
12M change
Total Value Held
$3.42 Million
LAWRENCE STEINMAN Transaction History
Also insider at
LS
Lawrence Steinman
Director
Palo Alto, CA